Related Experiment Video
Updated: Jul 20, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Mathematical modeling of vancomycin release from Poly-L-Lactic Acid-Coated implants
Papon Thamvasupong1, Kwanchanok Viravaidya-Pasuwat1,2
1Faculty of Engineering, Department of Chemical Engineering, King Mongkut's University of Technology Thonburi, Bangkok, Thailand.
Abstract:
This study aimed to develop a mathematical model to predict the release profile and antibacterial efficacy of a vancomycin delivery system integrated with poly(L-lactic acid)-coated bone implants specifically designed for bone plates. Using Fickian diffusion principles within an ANSYS-CFX computational fluid dynamic model, we validated the model against our in vitro vancomycin release and agar diffusion studies, as well as previously published in vivo data, confirming the reliability of the model. The model predictions demonstrated the effectiveness of the system in inhibiting bacterial growth in surrounding tissue with no observed toxicity, with a peak vancomycin concentration of 0.95 mg/ml at 6 hours, followed by a decrease to levels that remained effective for antibacterial activity. Furthermore, a sensitivity analysis revealed that the model is particularly sensitive to the half-life of vancomycin, with a maximum sensitivity index of 0.8, indicating its greater impact on the prediction accuracy than the diffusion coefficient, which has a maximum sensitivity index of 0.5. Therefore, precise input of vancomycin's half-life is critical for accurate predictions. These findings offer substantial support for the efficacy of the local delivery system as a promising therapeutic approach against implant-associated infections.
Related Concept Videos
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
In Vitro Drug Dissolution: Compendial Testing Models I
In Vitro Drug Dissolution: Compendial Testing Models II
Estimation of k and VD of Aminoglycosides
Modified-Release Drug Delivery Systems: Rate-Programmed II
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

